Lotus pharmaceutical

Lotus Pharmaceutical is an international pharmaceutical company with global influence, specializing in the commercialization of novel and generic drugs to provide patients with better, safer, and more accessible medications. The company possesses a recognized top-tier R&D and manufacturing platform in Asia and has established partnerships in nearly all global markets, including the United States, Europe, Japan, China, and Brazil. Lotus Pharmaceutical manages over 100 strategically selected pharmaceutical projects across Asia and the United States, which are currently in development and registration phases. Through internal R&D investments and collaborative licensing, the company invests in a diversified and optimal portfolio comprising high-barrier oncology, complex generics, 505(b)(2), and New Chemical Entities (NCEs). With support from strategic partners, Lotus Pharmaceutical enhances its portfolio competitiveness by incorporating biosimilar products. Its industry-leading infrastructure is certified by most of the world’s advanced regulatory authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), Japan’s PMDA, China’s National Medical Products Administration (NMPA), and Brazil’s ANVISA.